DFN15 Versus Placebo in Patients With Migraine Headaches
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2017
At a glance
- Drugs DFN 15 (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 11 Jun 2017 Results of post hoc analysis evaluating variability of migraine symptoms (n=60), presented at the 59th Annual Scientific Meeting of the American Headache Society.
- 11 Jun 2017 Results (n=60) presented at the 59th Annual Scientific Meeting of the American Headache Society.
- 07 Jul 2016 Status changed from active, no longer recruiting to completed.